You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -50.5% | -70.0% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.3 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 4.4 | 3.5 |
| Price / Book value | 6.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 19.2% | 4.7% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -14.4% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | 7.16 | -1.84 | $-15.18 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2015-12-31 | 9.29 | -1.45 | $-1.86 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 12.27 | -3.35 | $-0.11 | -15.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 13.98 | -9.92 | $-0.20 | -16.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 16.67 | -8.87 | $-0.17 | -14.2 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 15.81 | -11.06 | -17.36p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2020-12-31 | 18.82 | -10.52 | -17.90p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Maxcyte continues to build on 'substantial momentum' Sharecast News | 17 Jul |
|---|---|
| Sunday share tips: IQE, MaxCyte Sharecast News | 26 May |
| MaxCyte begins dosing second cohort in MCY-M11 clinical trial Sharecast News | 08 May |
| Result of AGM | 01-Nov-19 13:05 |
|---|---|
| MaxCyte Advances Phase I Clinical Trial | 24-Oct-19 07:04 |
| Notification of AGM and Audit Declaration | 08-Oct-19 07:06 |
| Editas Clinical and Commercial License Agreement | 07-Oct-19 07:04 |
| Updates on CARMA Platform at Upcoming Meetings | 30-Sep-19 07:07 |